...
首页> 外文期刊>Veterinary Immunology and Immunopathology >Evaluation of cytokines concentration and percentage of survival of rabies virus-infected mice submitted to anti-rabies Vero-cell propagated vaccine and P. acnes
【24h】

Evaluation of cytokines concentration and percentage of survival of rabies virus-infected mice submitted to anti-rabies Vero-cell propagated vaccine and P. acnes

机译:接受抗狂犬病Vero细胞繁殖疫苗和痤疮丙酸杆菌的狂犬病毒感染小鼠的细胞因子浓度和存活百分比的评估

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Previously, survival of rabies infection was shown to correlate with low IL-6 serum concentration in mice subjected to post-exposure treatment with the Fuenzalida Palacios rabies vaccine in conjunction with the immunomodulator Propionibacterium acnes, previously Corynebacterium parvum. Considering the substitution of the Fuenzalida Palacios rabies vaccine by the Vero cell raised anti-rabies vaccine in almost all countries, the objective of this work was to evaluate the survival and cytokine serum concentration of rabies virus-infected mice treated with P. acnes in conjunction with or the anti-rabies-VERO vaccine. For this, Swiss mice were experimentally infected with street rabies virus and subjected to vaccine and/or P. acnes following infection. Animals were killed at different times and serum was collected to evaluate cytokines. The greatest survival was observed in animals given one or two does of P. acnes in the absence of vaccination. Animals given anti-rabies VERO vaccine alone or with three doses of P. acnes had the second highest survival rate. The group that had the highest percentage of mortality also had the highest IL-6 concentration on the 10th day, a time correlating with clinical symptoms of the animals. The results reinforce the inefficacy of anti-rabies vaccine in only one dose as a post-exposure treatment irrespective of the type of vaccine used, the immunomodulation activity of P. acnes in rabies post-exposure treatment and suggest a role for IL-6 in rabies virus pathogenesis.
机译:以前,狂犬病感染的存活率与在用Fuenzalida Palacios狂犬病疫苗与免疫调节剂痤疮丙酸杆菌(先前为小棒杆菌)联合进行暴露后处理的小鼠中显示出低IL-6血清浓度相关。考虑到几乎所有国家都用Vero细胞引发的抗狂犬病疫苗替代了Fuenzalida Palacios狂犬病疫苗,这项工作的目的是评估联合用痤疮丙酸杆菌治疗的狂犬病病毒感染小鼠的存活率和细胞因子血清浓度。或带有抗狂犬病-VERO疫苗。为此,对瑞士小鼠进行实验性感染街头狂犬病毒,并在感染后对其进行疫苗和/或痤疮丙酸杆菌的治疗。在不同时间处死动物并收集血清以评估细胞因子。在不接种疫苗的情况下,给予一两次痤疮丙酸杆菌的动物观察到最大的存活率。仅接受抗狂犬病VERO疫苗或三剂痤疮丙酸杆菌的动物存活率第二高。死亡率最高的组在第10天的IL-6浓度也最高,这一时间与动物的临床症状相关。结果增强了抗狂犬病疫苗在暴露后治疗中仅一剂的无效性,而与所用疫苗的类型,痤疮丙酸杆菌在暴露后治疗中的痤疮丙酸杆菌的免疫调节活性无关,并暗示了IL-6在暴露后治疗中的作用。狂犬病病毒的发病机理。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号